Capital Research Global Investors Haemonetics Corp Transaction History
Capital Research Global Investors
- $428 Billion
- Q1 2024
A detailed history of Capital Research Global Investors transactions in Haemonetics Corp stock. As of the latest transaction made, Capital Research Global Investors holds 6,674,751 shares of HAE stock, worth $552 Million. This represents 0.13% of its overall portfolio holdings.
Number of Shares
6,674,751
Previous 6,523,568
2.32%
Holding current value
$552 Million
Previous $558 Million
2.13%
% of portfolio
0.13%
Previous 0.14%
Shares
23 transactions
Others Institutions Holding HAE
# of Institutions
310Shares Held
50.1MCall Options Held
161KPut Options Held
56.3K-
Black Rock Inc. New York, NY5.98MShares$495 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.4MShares$447 Million0.01% of portfolio
-
Wellington Management Group LLP Boston, MA4.27MShares$353 Million0.07% of portfolio
-
Neuberger Berman Group LLC New York, NY3.79MShares$313 Million0.27% of portfolio
-
State Street Corp Boston, MA1.83MShares$152 Million0.01% of portfolio
About HAEMONETICS CORP
- Ticker HAE
- Exchange NYSE
- Sector Healthcare
- Industry Medical Instruments & Supplies
- Shares Outstandng 51,316,500
- Market Cap $4.25B
- Description
- Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...